H Yki-Järvinen, R Kauppinen-Mäkelin, M … - Diabetologia, 2006 - Springer Page 1. Diabetologia (2006) 49: 442–451 DOI 10.1007/s00125-005-0132-0 ARTICLE H.
Yki-Järvinen . R. Kauppinen-Mäkelin . M. Tiikkainen . M. Vähätalo . ... Cited by 156 - Related articles - BL Direct - All 7 versions
V Fonseca, A Schweizer, D Albrecht, MA … - Diabetologia, 2007 - Springer Abstract Aims/hypothesis Type 2 diabetes is difficult to manage in patients with
a long history of disease requiring insulin therapy. Moreover, addition of most
currently available oral antidiabetic agents increases the risk of ... Cited by 104 - Related articles - BL Direct - All 4 versions
- ►adisonline.com [PDF] M Rendell - Drugs, 2004 - ingentaconnect.com The sulphonylureas act by triggering insulin release from the pancreatic β
cell. Abstract A specific site on the adenosine triphosphate (ATP)-sensitive
potassium channels is occupied by sulphonylureas leading to closure of the ... Cited by 86 - Related articles - BL Direct - All 7 versions
MG Wulffele, A Kooy, D Zeeuw, CDA … - Journal of Internal Medicine, 2004 - interscience.wiley.com It is also possible that your web browser is not configured or not able to
display style sheets. In this case, although the visual presentation will be
degraded, the site should continue to be functional. We recommend using the ... Cited by 81 - Related articles - BL Direct - All 6 versions
J Jager, A Kooy, PH Lehert, D Bets, MG … - Journal of internal medicine, 2005 - interscience.wiley.com It is also possible that your web browser is not configured or not able to
display style sheets. In this case, although the visual presentation will be
degraded, the site should continue to be functional. We recommend using the ... Cited by 80 - Related articles - BL Direct - All 6 versions
MC Riddle, DJ Drucker - Diabetes Care, 2006 - Am Diabetes Assoc Current therapies for type 2 diabetes are frequently associated with inadequate
control of postprandial hyperglycemia, weight gain, and, in the case of oral
agents, loss of efficacy over time. A better understanding of physiological ... Cited by 71 - Related articles - BL Direct - All 10 versions
- ►diabetesjournals.org SM Strowig, ML Avilés-Santa, P Raskin - Diabetes Care, 2004 - Am Diabetes Assoc RESULTS—HbA 1c levels decreased in both groups during dual therapy and
improved further during triple therapy (INS + MET 7.0 ± 0.8, INS + TGZ 6.2 ±
0.8, P < 0.0001; INS + MET, add TGZ 6.1 ± 0.4%, P < 0.001; INS + TGZ, add ... Cited by 49 - Related articles - BL Direct - All 5 versions
MG Wulffele, A Kooy, P Lehert, D Bets, JC … - Journal of internal medicine, 2003 - pt.wkhealth.com Objective: Metformin is a key treatment option in type 2 diabetes. However,
metformin may decrease vitamin B12 levels and increase levels of homo-cysteine,
a cardiovascular risk factor. We investigated whether 16 weeks of treatment ... Cited by 39 - Related articles - BL Direct - All 5 versions
G Dailey - Clinical therapeutics, 2004 - Elsevier Results: Large-scale intervention trials, such as the United Kingdom Prospective
Diabetes Study (UKPDS), have reported that patients with type 2 DM treated with
oral combination therapy are unable to maintain glycemic control. These ... Cited by 34 - Related articles - All 4 versions
- ►hospitalprivadosa.com.ar [PDF] T Davis, SV Edelman - Medical Clinics of North America, 2004 - Elsevier Type 2 diabetes leads to a tremendous amount of death and disability and uses a
large portion of the health care dollar [4]. Although diabetes is associated
with multiple disorders with distinct pathologic mechanisms, insulin ... Cited by 25 - Related articles - BL Direct - All 4 versions
